SEMI-G is known as a diabetes therapy almost as much as it is known for being a weight management peptide. 

SEMI-G is used for weight loss in specific patients, and also to lower blood sugar levels, and to reduce the risk of major cardiovascular events such as heart attack or stroke in certain patients. SEMI-G is the active ingredient in Ozempic, Wegovy, and Rybelsus. SEMI-G is a agonist that increases insulin release, lowers the amount of glucagon released, delays gastric emptying, and reduces appetite.

Usually, when people take SEMI-G for weight management, they also take a B-12 supplement like the Hycomin product we sell.

NOTE:  Pure Raw Powder is used for manufacturing research peptide vials. 

Check out Jay Campbell's website, which is an excellent source for peptide research.